PhorMed is a clinical stage biopharmaceutical company.
PhorMed has raised $239K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in August 2022.
PhorMed's investors include Meyer Global.
PhorMed is headquartered in Beverly Hills, United States.
PhorMed is a clinical stage biopharmaceutical company.
PhorMed is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhorMed — Funding & Investors." VCBacked, August 18, 2022, https://www.vcbacked.co/company/phormed. Accessed August 14, 2026.
VCBacked. (2022). PhorMed — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/phormed
{{cite web |title=PhorMed — Funding & Investors |url=https://www.vcbacked.co/company/phormed |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated